iShares Health Innovation Active ETF (NYSEARCA:BMED) Short Interest Update

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the target of a significant decrease in short interest in the month of July. As of July 15th, there was short interest totaling 1,114 shares, a decrease of 39.2% from the June 30th total of 1,831 shares. Based on an average daily trading volume, of 3,283 shares, the short-interest ratio is currently 0.3 days. Approximately 0.3% of the company’s shares are short sold.

iShares Health Innovation Active ETF Stock Up 0.0%

Shares of BMED traded up $0.01 during trading hours on Thursday, hitting $31.25. The company had a trading volume of 171 shares, compared to its average volume of 3,566. iShares Health Innovation Active ETF has a 52-week low of $24.50 and a 52-week high of $32.19. The stock’s 50 day moving average price is $29.62 and its 200 day moving average price is $29.61. The firm has a market cap of $11.25 million, a P/E ratio of 24.91 and a beta of 0.73.

Institutional Trading of iShares Health Innovation Active ETF

A hedge fund recently bought a new stake in iShares Health Innovation Active ETF stock. Sunbelt Securities Inc. acquired a new stake in shares of iShares Health Innovation Active ETF (NYSEARCA:BMED) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 11,612 shares of the company’s stock, valued at approximately $352,000. Sunbelt Securities Inc. owned 3.63% of iShares Health Innovation Active ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.